Related Experiment Videos

Targeted Epigenetic Silencing of Jumonji Domain-Containing Protein 3 Alleviates Nuclear Factor-Kappa B-Mediated

Ghada Nour Eldeen1, Mona F Sokkar1, Randa S Lotfy1

  • 1Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre, Egypt.

Abstract

Insights

In Familial Mediterranean Fever (FMF), inhibiting JMJD3 with GSK-J4 suppressed inflammasome activation and reduced key inflammatory markers. This highlights JMJD3 as a potential therapeutic target for autoinflammatory diseases.

Area of Science:

  • Inflammation research
  • Molecular biology
  • Genetics

Background:

  • Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease linked to MEFV gene variants and inflammasome dysregulation.
  • Nuclear factor-kappa B (NF-κB) is a key mediator of chronic inflammation in autoinflammatory conditions.
  • Jumonji domain-containing protein 3 (JMJD3) is an epigenetic regulator implicated in inflammation, with its inhibitor GSK-J4 showing potential therapeutic benefits.

Purpose of the Study:

  • To investigate the role of JMJD3 and NF-κB-JMJD3 signaling in inflammation.
  • To evaluate the efficacy of GSK-J4 in inhibiting inflammasome activation in FMF patient cells.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from FMF patients were cultured and stimulated.
  • Cells were treated with GSK-J4 or subjected to JMJD3 knockdown via siRNA.
  • Inflammatory markers and gene expression were analyzed using Western blotting, ELISA, and qRT-PCR.

Main Results:

  • GSK-J4 treatment significantly downregulated NF-κB, NLRP3, and inflammatory cytokine gene expression.
  • Western blotting confirmed reduced NF-κB levels post-GSK-J4 treatment.
  • JMJD3 knockdown also decreased inflammatory markers, confirming its pro-inflammatory role.

Conclusions:

  • Selective inhibition or silencing of JMJD3 effectively suppresses inflammasome activation in FMF.
  • JMJD3 represents a promising therapeutic target for managing inflammation in FMF and other autoinflammatory diseases.

Related Concept Videos

NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...